Timothy Murray1, Thomas Rodt2, Michael J Lee3. 1. Department of Radiology, Beaumont Hospital, Dublin, Ireland. 2. Department of Radiology, Hannover Medical School, Hannover, Germany. 3. Department of Radiology, Beaumont Hospital, Dublin, Ireland mlee@rcsi.ie.
Abstract
PURPOSE: To report the feasibility, technical considerations, and initial results of 2-dimensional (2D) perfusion angiography of the foot before and after endovascular interventions. METHODS: A retrospective single-center study involved 21 patients (mean age 73.4±10.5 years; 14 men) with severe peripheral vascular disease [Fontaine stage III (n=10) or IV (n=14)] who underwent lower limb digital subtraction angiography (DSA) prior to and following endovascular treatment of above- and/or below-knee lesions. A standardized contrast administration protocol (15 mL iodixanol 320 mg I/mL at 3 mL/s via a 5/6-F antegrade sheath) was applied during DSA using a 2D perfusion-enabled image intensifier. Representative hindfoot and forefoot regions of interest were analyzed, and representative numeric density values [time to peak (TTP), peak density value (PDV), and area under the (time-density) curve (AUC)] were calculated using 2D perfusion-enabled angiographic software to assess foot perfusion. Values were compared before and after angioplasty and by level of treatment (above or below knee). The parameters were correlated with disease severity (stenosis vs occlusion) and symptom level (Fontaine stage). RESULTS: A clinically significant improvement (29.4%) in the AUC was noted following angioplasty, reaching statistical significance within the hindfoot (p=0.03). No significant change in TTP or PDV was detected following angioplasty. Foot movement remained problematic when measuring time-density values. No statistical difference in perfusion values was appreciable between above- and below-knee angioplasty. CONCLUSION: Two-dimensional perfusion angiography of the foot allows quantitative evaluation using various density values with potential benefit for treatment planning and technical outcome analysis. Methodical restrictions currently remain, mainly regarding patient movement.
PURPOSE: To report the feasibility, technical considerations, and initial results of 2-dimensional (2D) perfusion angiography of the foot before and after endovascular interventions. METHODS: A retrospective single-center study involved 21 patients (mean age 73.4±10.5 years; 14 men) with severe peripheral vascular disease [Fontaine stage III (n=10) or IV (n=14)] who underwent lower limb digital subtraction angiography (DSA) prior to and following endovascular treatment of above- and/or below-knee lesions. A standardized contrast administration protocol (15 mL iodixanol 320 mg I/mL at 3 mL/s via a 5/6-F antegrade sheath) was applied during DSA using a 2D perfusion-enabled image intensifier. Representative hindfoot and forefoot regions of interest were analyzed, and representative numeric density values [time to peak (TTP), peak density value (PDV), and area under the (time-density) curve (AUC)] were calculated using 2D perfusion-enabled angiographic software to assess foot perfusion. Values were compared before and after angioplasty and by level of treatment (above or below knee). The parameters were correlated with disease severity (stenosis vs occlusion) and symptom level (Fontaine stage). RESULTS: A clinically significant improvement (29.4%) in the AUC was noted following angioplasty, reaching statistical significance within the hindfoot (p=0.03). No significant change in TTP or PDV was detected following angioplasty. Foot movement remained problematic when measuring time-density values. No statistical difference in perfusion values was appreciable between above- and below-knee angioplasty. CONCLUSION: Two-dimensional perfusion angiography of the foot allows quantitative evaluation using various density values with potential benefit for treatment planning and technical outcome analysis. Methodical restrictions currently remain, mainly regarding patient movement.
Authors: Sabine K Maschke; Julius Renne; Thomas Werncke; Karen M Olsson; Marius M Hoeper; Frank K Wacker; Bernhard C Meyer; Jan B Hinrichs Journal: Eur Radiol Date: 2017-03-30 Impact factor: 5.315
Authors: Jan B Hinrichs; Tim Murray; Muharrem Akin; Michael Lee; Micheal Ulrich Brehm; Mathias Wilhelmi; Frank K Wacker; Thomas Rodt Journal: Int J Cardiovasc Imaging Date: 2016-10-26 Impact factor: 2.357
Authors: Katsuyuki Taguchi; Thomas J Sauer; W Paul Segars; Eric C Frey; Jingyan Xu; Eleni Liapi; J Webster Stayman; Kelvin Hong; Ferdinand K Hui; Mathias Unberath; Yong Du Journal: Med Phys Date: 2020-10-22 Impact factor: 4.071
Authors: Lena S Becker; Klaus Stahl; Timo C Meine; Christian von Falck; Bernhard C Meyer; Cornelia L A Dewald; Nina Rittgerodt; Markus Busch; Sascha David; Frank Wacker; Jan B Hinrichs Journal: Abdom Radiol (NY) Date: 2020-10
Authors: Timo C Meine; Sabine K Maschke; Martha M Kirstein; Elmar Jaeckel; Becker S Lena; Thomas Werncke; Cornelia L A Dewald; Frank K Wacker; Bernhard C Meyer; Jan B Hinrichs Journal: Medicine (Baltimore) Date: 2021-02-19 Impact factor: 1.817
Authors: Cornelia L A Dewald; Lena S Becker; Sabine K Maschke; Timo C Meine; Bernhard C Meyer; Frank K Wacker; Jan B Hinrichs Journal: Cardiovasc Intervent Radiol Date: 2020-12-16 Impact factor: 2.740
Authors: Anne Marie Augustin; Franziska Wolfschmidt; Thilo Elsässer; Alexander Sauer; Alexander Dierks; Thorsten Alexander Bley; Ralph Kickuth Journal: BMC Med Imaging Date: 2022-02-04 Impact factor: 1.930
Authors: Nina Rittgerodt; Thorben Pape; Sascha David; Klaus Stahl; Markus Busch; Lena S Becker; Andrea Schneider; Heiner Wedemeyer; Benjamin Seeliger; Julius Schmidt; Anna Maria Hunkemöller; Jan Fuge; Wolfgang Knitsch; Christine Fegbeutel; Hans-Jörg Gillmann; Bernhard C Meyer; Marius M Hoeper; Jan B Hinrichs Journal: Crit Care Date: 2022-04-04 Impact factor: 9.097
Authors: Martina Gurgitano; Giulia Signorelli; Giovanni Maria Rodà; Alessandro Liguori; Marco Pandolfi; Giuseppe Granata; Antonio Arrichiello; Anna Maria Ierardi; Aldo Paolucci; Gianpaolo Carrafiello Journal: Acta Biomed Date: 2020-09-23